IRCT2012103111339N1Completed未知
Comparison of Montelukast and placebo in the prevention of upper respiratory infections in children 1 to 5 years
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 380
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 year to 5 years (—)
- Sex
- All
Inclusion Criteria
- •Lack of hyper reactive airway disease;No history of allergic rhinitis;Not taking any medication for a chronic;Absence of chronic heart disease or chronic respiratory disease:
- •Exclusion criteria
- •Hyper reactive airway disease (previously treated with bronchodilators in the last three months, Or more than once treatment in the past year or hospitalization for treatment or prophylaxis in recent years with Monteluckast or steroids);History of allergic rhinitis;Taking any medication for a chronic; Chronic heart disease or chronic respiratory disease;Known hypersensitivity to Montelukast;Active URI within one week ago
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 2
Comparison of the effects of Oral Montelukast with Oral Zileuton in sudden attack of asthma.CTRI/2013/12/004260Dr Shahul Hameed Aboobackar120
Completed
Phase 3
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
Recruiting
Phase 2
Evaluation of the effect of Montelukast in allergic rhinitis, Evaluation of the effect of neotadine in the treatment of allergic rhinitisIRCT20211205053277N1Tehran University of Medical Sciences60
Completed
Phase 3
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80
Completed
Phase 3
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)Seasonal Allergic RhinitisNCT00972738Organon and Co1,214